scholarly journals What weight loss treatment options do geriatric patients with overweight and obesity want to consider?

2016 ◽  
Vol 2 (4) ◽  
pp. 477-482
Author(s):  
M. MacMillan ◽  
K. Cummins ◽  
K. Fujioka
Keyword(s):  
Weight Loss ◽  
Geriatric Patients ◽  
Treatment Options ◽  
Overweight And Obesity ◽  
Weight Loss Treatment

scholarly journals Perceived Barriers and Facilitators to Healthy Lifestyles and Weight Loss Among Adolescents with Overweight and Obesity: A Qualitative Study

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1614-1614
Author(s):  
Michelle Cardel ◽  
Alexandra Lee ◽  
Jackson Dillard ◽  
Abhaya Dilip ◽  
Darci Miller ◽  
...  
Keyword(s):  
Weight Loss ◽  
Qualitative Study ◽  
Weight Status ◽  
Healthy Lifestyle ◽  
Treatment Options ◽  
Overweight And Obesity ◽  
Perceived Barriers ◽  
Barriers And Facilitators ◽  
Blood Institute ◽  
Management Interventions

Abstract Objectives Obesity in adolescence has reached epidemic proportions around the world, with the prevalence of severe obesity increasing at least four-fold over the last 35 years. Provision of evidence-based treatment options that are tailored and relevant to the needs of adolescents is paramount, yet difficult to tailor because little is known regarding barriers and facilitators to adolescent weight loss. Thus, identification of barriers and facilitators to weight loss among adolescents with overweight/obesity (OW/OB) is needed. The objective of this qualitative study was to assess perceived barriers and facilitators to a healthy lifestyle and weight loss among adolescents with OW/OB. Methods Using 2018–2019 data from eleven focus groups among adolescents aged 14–19 with OW/OB (n = 41; n = 11 boys and n = 30 girls), a moderated, semi-structured focus group guide was used to identify perceived barriers and facilitators to a healthy lifestyle and weight loss. Results Adolescents reported time, access to healthful foods, food cravings, stress, and weight stigma/shaming as barriers to weight loss. Themes around internal and external psychosocial states (support, motivation) and behaviors including modeling, sports, and other physical activities were identified as both barriers and facilitators. Parents were recognized by teens as both helping and hindering weight loss, but overall teens felt their parents were more so facilitators than barriers, particularly as it related to modeling behaviors. Differences were noted by sex, among which girls reported experiencing weight struggles, whereas boys generally stated they did not struggle with weight, despite all participants meeting criterion for OW/OB. Conclusions Adolescent boys and girls with OW/OB perceive their weight status differently and identify a variety of barriers and facilitators to a healthy lifestyle and weight loss. Tailoring adolescent weight management interventions to address these perceived barriers and facilitators, along with noted sex differences, has the potential to improve the quality and effectiveness of adolescent obesity interventions. Funding Sources National Heart, Lung, and Blood Institute, National Institute of Health, WellCare Health Plans.

Abstract P241: 2013 AHA/ACC/TOS and 1998 NHLBI Clinical Guidelines for the Management of Overweight and Obesity Predict Higher Cardiovascular Disease Risk in Adults Recommended versus Not Recommended for Weight Loss Treatment: the Atherosclerosis Risk in Communities Study

Circulation ◽  
2015 ◽  
Vol 131 (suppl_1) ◽  
Author(s):  
June Stevens ◽  
Eva Erber-Oakkar ◽  
Zhaohui Cui ◽  
Jianwen Cai ◽  
David Wormser ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Weight Loss ◽  
Waist Circumference ◽  
Disease Risk ◽  
Primary Care Providers ◽  
Overweight And Obesity ◽  
Care Providers ◽  
Cvd Risk ◽  
Weight Loss Treatment

Introduction: In 2013, AHA/ACC/TOS released an algorithm to assist primary care providers in the identification of patients who should be considered for weight loss treatment to promote the prevention and treatment of cardiovascular disease (CVD). This guidance updated the recommendations released in 1998 by NHLBI. We know of no studies that have compared risk of incident CVD in adults recommended or not recommended for treatment by these two guidelines. Hypothesis: We hypothesized that adults recommended for weight loss treatment by the 1998 and 2013 algorithms have higher CVD risk than those not recommended for treatment. Additional analyses explored sources of differences in the algorithms as predictors of CVD risk. Methods: The ARIC study included 13,020 African American and White adults aged 45-64 years. Baseline data collected in 1987-1989 on BMI, waist circumference and other CVD risk factors in participants were used to form treatment groups that differed between the algorithms in regard to the choice, definition and number of risk factors. We calculated hazard ratios (HR) for first CVD event defined as ischemic stroke, fatal and non-fatal myocardial infarction (MI), silent MI and coronary revascularization procedures. Covariates included age, gender, ethnicity and study center. Results: At baseline, mean BMI was 28 kg/m2 (SD 5.3). During a median follow-up of 19.8 years, 2,698 incident CVD outcomes were recorded. The 1998 and 2013 algorithms recommended weight loss for 58% and 63% of participants, respectively, with 13% discrepant. The HR for CVD in adults recommended vs not recommended for treatment were 1.85 (95% CI: 1.69, 2.00) for the 1998 algorithm and 1.59 (95% CI: 1.47, 1.72) for the 2013 algorithm. The higher HR for the 1998 algorithm was driven in part by the inclusion of three risk factors (age, smoking and family history of premature CHD) not included in the 2013 algorithm (1998 HR reduced from 1.85 to 1.78 (95% CI: 1.65, 1.93) when those risk factors omitted). In the 2013, but not the 1998 algorithm, all overweight adults with a large waist circumference or pre-diabetes as their only risk factor were included in the treated group, but the HR’s for those subgroups were not elevated. The 2013 HR changed from 1.59 to 1.77 (95% CI: 1.63, 1.93) when those criteria were omitted. Conclusions: Both algorithms identified patients for weight loss treatment who were at elevated CVD risk, and the difference in the HR’s associated with the algorithms can be explained by differences in the specification of risk factors.

Behavioural weight loss treatment preferences of college students with overweight and obesity

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Jessica D. Bihuniak ◽  
Tiffany Bryant ◽  
Jennifer Kleiman ◽  
Megan Rotondo ◽  
Jessica Decoteau ◽  
...  
Keyword(s):  
College Students ◽  
Weight Loss ◽  
Overweight And Obesity ◽  
Treatment Preferences ◽  
Weight Loss Treatment

Continuation of weight loss treatment is associated with the number of self-selected treatment modalities.

2007 ◽  
Vol 3 (3) ◽  
pp. 394-402 ◽  
Author(s):  
Corby K. Martin ◽  
Danae L. Drab-Hudson ◽  
Emily York-Crowe ◽  
Stephen B. Mayville ◽  
Ying Yu ◽  
...  
Keyword(s):  
Weight Loss ◽  
Treatment Modalities ◽  
Weight Loss Treatment

Reframing Fatness: Critiquing ‘Obesity’

2018 ◽  
Author(s):  
Bethan Evans ◽  
Charlotte Cooper
Keyword(s):  
Public Health ◽  
Weight Loss ◽  
Michel Foucault ◽  
Overweight And Obesity ◽  
Health Concern ◽  
Public Health Concern ◽  
Policy Language ◽  
Religious Imagery ◽  
Fat Bodies

Over the last twenty years or so, fatness, pathologised as overweight and obesity, has been a core public health concern around which has grown a lucrative international weight loss industry. Referred to as a ‘time bomb’ and ‘the terror within’, analogies of ‘war’ circulate around obesity, framing fatness as enemy.2 Religious imagery and cultural and moral ideologies inform medical, popular and policy language with the ‘sins’ of ‘gluttony’ and ‘sloth’, evoked to frame fat people as immoral at worst and unknowledgeable victims at best, and understandings of fatness intersect with gender, class, age, sexuality, disability and race to make some fat bodies more problematically fat than others. As Evans and Colls argue, drawing on Michel Foucault, a combination of medical and moral knowledges produces the powerful ‘obesity truths’ through which fatness is framed as universally abject and pathological. Dominant and medicalised discourses of fatness (as obesity) leave little room for alternative understandings.

Liraglutide for the Treatment of Obesity: Analyzing Published Reviews

2019 ◽  
Vol 25 (15) ◽  
pp. 1783-1790 ◽  
Author(s):  
Rosario Pastor ◽  
Josep A. Tur
Keyword(s):  
Weight Loss ◽  
Clinical Trials ◽  
Systematic Reviews ◽  
Randomized Clinical Trials ◽  
Statistical Tests ◽  
Overweight And Obesity ◽  
Cochrane Library ◽  
Medical Subject Headings ◽  
Mesh Terms ◽  
Treatment Of Obesity

Background: Several drugs have been currently approved for the treatment of obesity. The pharmacokinetic of liraglutide, as well as the treatment of type 2 diabetes mellitus, have been widely described. Objective: To analyze the published systematic reviews on the use of liraglutide for the treatment of obesity. Methods: Systematic reviews were found out through MEDLINE searches, through EBSCO host and the Cochrane Library based on the following terms: "liraglutide" as major term and using the following Medical Subject Headings (MesH) terms: "obesity", "overweight", "weight loss". A total of 3 systematic reviews were finally included to be analyzed. Results: From the three systematic reviews selected, only two included the randomized clinical trials, while the third study reviewed both randomized and non-randomized clinical trials. Only one review performed statistical tests of heterogeneity and a meta-analysis, combining the results of individual studies. Another review showed the results of individual studies with odds ratio and confidence interval, but a second one just showed the means and confidence intervals. In all studies, weight loss was registered in persons treated with liraglutide in a dose dependent form, reaching a plateau at 3.0 mg dose, which was reached just in men. Most usual adverse events were gastrointestinal. Conclusion: More powerful and prospective studies are needed to assess all aspects related to liraglutide in the overweight and obesity treatment.

Sign in / Sign up

Export Citation Format

Share Document